TY  - RPRT
TI  - Loss of KDM6A-mediated genomic instability and metabolic reprogramming differentially regulates responses to immune checkpoint therapy and chemotherapy in bladder cancer.
AU  - Singh, P.
AU  - Raychaudhuri, D.
AU  - Chakraborty, B.
AU  - Meher, S.
AU  - Tannir, A. J.
AU  - Majumdar, A.
AU  - Hawkins, J.
AU  - Xiong, Y.
AU  - Lorenzi, P.
AU  - Sharma, P.
AU  - Pilie, P.
AU  - Goswami, S.
PY  - 2024
DO  - 10.1101/2024.10.31.621396
UR  - https://www.biorxiv.org/content/10.1101/2024.10.31.621396v1
ID  - 10.1101/2024.10.31.621396
ER  -